Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-053514
Filing Date
2025-04-14
Accepted
2025-04-14 08:19:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A kpti-defa14a-2025.htm DEFA14A 26187
2 GRAPHIC img184706079_0.jpg GRAPHIC 550940
3 GRAPHIC img184706079_1.jpg GRAPHIC 449258
  Complete submission text file 0000950170-25-053514.txt   1404320
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

EIN.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36167 | Film No.: 25834267
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)